GAIN THERAPEUTICS, INC — Net Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f7fb60a2-177a-4e8b-94a8-0fb98d163f0e/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-20.2M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-035188 |
| FY 2024 | $-20.4M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-003823 |
| FY 2023 | $-22.3M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-003943 |
| FY 2022 | $-17.6M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-004460 |
| FY 2021 | $-13.9M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-004363 |
| FY 2020 | $-3.6M | 2020-01-01 – 2020-12-31 | evidence 0001558370-22-004363 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
GAIN THERAPEUTICS, INC — all facts · Revenue · Operating Income